financial-services
Exclusive-Boeing Set to Win Conditional EU Okay for $4.7 Billion Spirit Deal, Sources Say
Soccer-Security Concerns Overshadow Israel's World Cup Qualifiers in Norway and Italy
HeadlinesMayor in Western Germany in Intensive Care After Stabbing
UK Competition Watchdog to Probe Sumitomo's Macquarie Helicopter Deal
New Satellite Plant to Open in Italy to Boost Production Capacity
Date: October 7, 2025
MILAN (Reuters) -Italy's space agency and Thales Alenia Space, a joint venture between Italian aerospace group Leonardo and France's Thales, will begin operations at one of Europe's largest satellite...
Russia's Pipeline Deal With China Seen Taking a Decade to Boost Exports
Date: October 7, 2025
MOSCOW (Reuters) -Russia, which recently announced progress in talks with Beijing about a new pipeline, will need at least a decade to significantly increase natural gas exports to China as a result...
Reactions to Two-Year Anniversary of Hamas Attack on Israel
Date: October 7, 2025
(Reuters) -Tuesday marked the two-year anniversary of Palestinian militant group Hamas' attack on Israel that triggered the ongoing offensive in the Gaza Strip. Following are reactions from world...
Airbus A320 Flies Past Boeing 737 as Most-Delivered Jet in History
Date: October 7, 2025
PRAGUE (Reuters) -Europe's Airbus broke a major commercial barrier on Tuesday when its A320 family of planes overtook the Boeing 737 to become the most-delivered jetliner in history. Boeing's decades-...
Analysis-Private Credit Cash Pivots From 'risky' West to Emerging Markets
Date: October 7, 2025
By Libby George and Rodrigo Campos LONDON/NEW YORK (Reuters) -An intricate series of pipes off Angola's Atlantic coast snakes toward a new fuel refinery that signals the country's push for energy...
AstraZeneca Drug Baxdrostat Cuts Blood Pressure in Key Late-Stage Trial
Date: October 7, 2025
(Corrects day in paragraph 1) (Reuters) -AstraZeneca said on Tuesday its experimental drug baxdrostat significantly lowered blood pressure during a 24-hour window of monitoring in a late-stage trial...